ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.540
+0.040 (2.67%)
At close: Jun 6, 2025, 4:00 PM
1.580
+0.040 (2.60%)
After-hours: Jun 6, 2025, 7:25 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $25.03 million as of June 6, 2025. Its market cap has increased by 113.90% in one year.
Market Cap
25.03M
Enterprise Value
27.69M
1-Year Change
113.90%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $25.03M, a decrease of -68.52%. That is a compound annual growth rate of -25.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 25.80M | 235.06% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 688.17B |
| Johnson & Johnson | 371.73B |
| AbbVie | 334.84B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.76B |
| Abbott Laboratories | 231.80B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |